Category: Press Release

Congratulations to Even Keller on joining OVPR as the inaugural Director of Research Cores.

The collaboration developed a new photonic effect which could speed up the development of new antibiotics and drugs through automation.

The Biointerfaces Institute is pleased to welcome our Inaugural Innovation Fellows, Dr. Anastasia Visheratina and Dr. Dylan Neale.

The new nanoparticle discovery will revolutionize intravenous cancer immunotherapy.

Lola Eniola-Adefeso named new Associate Dean for Graduate & Professional Education (ADGPE) in the College of Engineering

The BioInnovations in Brain Cancer Initiative (BIBC) at the University of Michigan invites applications for a tenure-track position at any level in brain cancer biology and technology research (including, drug/molecular transport/imaging in the brain tissue; translation-focused glioma, epigenetics and/or scRNA-seq research; and non-viral nucleic acid delivery).

Applications will be accepted on a rolling basis, but review of applications will begin on October 1, 2021.

Researchers in the Tessier lab found a simple method for identifying nanobodies with drug-like properties suitable for preventing COVID-19 infections, which likely can be used to develop nanobodies against other viruses and disease targets.

Congratulations to James Moon, Sunitha Nagrath, Anna Schwendeman and Anish Tuteja on being promoted to Professor!

Under this license and collaboration agreement, EVOQ and Amgen will work on discovery and development of drugs for autoimmune disorders.

MichBio welcomed Lola Eniola-Adefeso to its Board of Directors where she will aid in the company’s efforts to drive future bio-industry growth.